NEVVI Medicare utilization intelligence

← back

PORTA, JENNIFERD.O NPI 1699209478 Clinician

Hematology-Oncology · SPRINGDALE, AR

Specialty Hematology-Oncology — from billed Medicare claims
Trained LINCOLN MEM UNIV, DEBUSK COL OF OSTEOPATHIC MED — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location SPRINGDALE, AR · NPPES registered location
Active in data Billed Medicare 2023–2024 (2 consecutive years)
Scale 106 codes billed · 129,079 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20242026
HIGHLANDS ONCOLOGY GROUP PA
2024–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-08

Year: 2024 · 2023

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9271 Injection, pembrolizumab, 1 mg
A9575 Injection, gadoterate meglumine, 0.1 ml
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1071 Injection, testosterone cypionate, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J2405 Injection, ondansetron hydrochloride, per 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
J2469 Injection, palonosetron hcl, 25 mcg
80053 Blood test, comprehensive group of blood chemicals
83735 Magnesium level
82248 Bilirubin level, direct
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
84100 Phosphate level
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J9045 Injection, carboplatin, 50 mg
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3480 Injection, potassium chloride, per 2 meq
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82784 Gammaglobulin (immune system protein) measurement
A9573 Injection, gadopiclenol, 1 ml
J3489 Injection, zoledronic acid, 1 mg
96375 Injection of additional new drug or substance into vein
71260 Ct scan of chest with contrast
74178 Ct scan of abdomen and pelvis before and after contrast
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J3490 Unclassified drugs
84443 Blood test, thyroid stimulating hormone (tsh)
J3475 Injection, magnesium sulfate, per 500 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
J7030 Infusion, normal saline solution , 1000 cc
82306 Vitamin d-3 level
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
36415 Insertion of needle into vein for collection of blood sample
83521 Measurement of immunoglobulin light chains
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96415 Administration of chemotherapy into vein, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82977 Glutamyltransferase (liver enzyme) level
A9596 Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
84436 Thyroxine (thyroid chemical), total
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82378 Carcinoembryonic antigen (cea) protein level
70553 Mri scan of brain before and after contrast
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
82533 Cortisol (hormone) measurement, total
96411 Administration of additional new drug or substance into vein using push technique
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
71046 X-ray of chest, 2 views
85045 Red blood count, automated test
82565 Blood creatinine level
81003 Automated urinalysis test
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
96374 Injection of drug or substance into vein
70491 Ct scan of soft tissue of neck with contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96361 Infusion into a vein for hydration, each additional hour
99239 Hospital discharge day management, more than 30 minutes
84153 Psa (prostate specific antigen) measurement, total
81001 Manual urinalysis test with examination using microscope, automated
70470 Ct scan of head or brain before and after contrast
98976 Device supply with scheduled recording and transmission for remote monitoring of respiratory system, per 30 days
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
71250 Ct scan of chest without contrast
82232 Beta-2 microglobulin (protein) level
96523 Irrigation of implanted venous access drug delivery device
84439 Thyroxine (thyroid chemical), free
78816 Nuclear medicine study whole body with ct scan
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
80400 Hormonal panel for adrenal gland assessment (adrenal gland insufficiency)
76705 Limited ultrasound scan of abdomen
98977 Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days
72197 Mri scan of pelvis before and after contrast
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
90653 Influenza vaccine, inactivated
76536 Ultrasound scan of head and neck soft tissue
G0008 Administration of influenza virus vaccine

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.